Early Prediction of Objective Response of Fibrinogen in a Real-World Cohort of Hepatocellular Carcinoma Cases Treated by Programmed Cell Death Receptor-1 and Lenvatinib.

Shen, Yanjun; Wang, Huige; Wei, Jianying; Li, Wendong

Shen, Yanjun; Wang, Huige; Wei, Jianying; Li, Wendong.

Afiliação

Shen Y; Department of Oncology, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China.
Wang H; Department of Gynecology, Wangjing Hospital of Chinese Academy of Chinese Medical, Beijing, 100102, People's Republic of China.
Wei J; Department of Oncology, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China.
Li W; Department of Oncology, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China.

Onco Targets Ther ; 14: 5019-5026, 2021.

Article em En | MEDLINE | ID: mdl-34675546

Palavras-chave

FIB; PD-1; hepatocellular carcinoma; lenvatinib; prediction

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Onco Targets Ther Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google